Universal Beteiligungs und Servicegesellschaft mbH trimmed its holdings in shares of MetLife, Inc. (NYSE:MET - Free Report) by 12.5% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 665,218 shares of the financial services provider's stock after selling 95,227 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH owned about 0.10% of MetLife worth $53,410,000 at the end of the most recent reporting period.
Several other institutional investors also recently bought and sold shares of the business. Ball & Co Wealth Management Inc. purchased a new stake in shares of MetLife during the fourth quarter worth about $25,000. Transce3nd LLC acquired a new position in shares of MetLife in the 4th quarter valued at approximately $26,000. North Capital Inc. purchased a new position in shares of MetLife during the 1st quarter valued at approximately $26,000. Quarry LP acquired a new stake in MetLife in the fourth quarter valued at $31,000. Finally, Graney & King LLC bought a new position in MetLife during the 4th quarter valued at $34,000. 94.99% of the stock is currently owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
Several equities analysts have recently commented on MET shares. JPMorgan Chase & Co. increased their price target on shares of MetLife from $86.00 to $95.00 and gave the stock an "overweight" rating in a research report on Tuesday, July 8th. Wells Fargo & Company reiterated an "overweight" rating and issued a $97.00 target price (up previously from $94.00) on shares of MetLife in a research report on Thursday, July 10th. Piper Sandler raised their price objective on MetLife from $92.00 to $94.00 and gave the stock an "overweight" rating in a research note on Wednesday, April 2nd. Keefe, Bruyette & Woods lowered their target price on shares of MetLife from $95.00 to $94.00 and set an "outperform" rating for the company in a research note on Wednesday, July 9th. Finally, Wall Street Zen downgraded shares of MetLife from a "buy" rating to a "hold" rating in a research report on Saturday, May 24th. Two equities research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $96.09.
View Our Latest Stock Analysis on MET
MetLife Stock Performance
Shares of MET traded up $0.54 during mid-day trading on Friday, reaching $78.33. 1,065,480 shares of the company's stock traded hands, compared to its average volume of 3,355,790. The company has a debt-to-equity ratio of 0.55, a quick ratio of 0.16 and a current ratio of 0.16. The business's 50-day moving average price is $78.72 and its 200-day moving average price is $79.72. The stock has a market capitalization of $52.58 billion, a P/E ratio of 12.73, a price-to-earnings-growth ratio of 0.64 and a beta of 0.85. MetLife, Inc. has a 12 month low of $65.21 and a 12 month high of $89.05.
MetLife (NYSE:MET - Get Free Report) last announced its earnings results on Wednesday, April 30th. The financial services provider reported $1.96 earnings per share for the quarter, missing the consensus estimate of $2.00 by ($0.04). MetLife had a net margin of 6.08% and a return on equity of 20.89%. The business had revenue of $18.57 billion for the quarter, compared to the consensus estimate of $18.06 billion. During the same period in the previous year, the firm earned $1.83 EPS. The firm's revenue was up 15.6% on a year-over-year basis. Equities analysts predict that MetLife, Inc. will post 9.65 earnings per share for the current year.
MetLife declared that its board has initiated a stock buyback plan on Wednesday, April 30th that authorizes the company to repurchase $3.00 billion in outstanding shares. This repurchase authorization authorizes the financial services provider to reacquire up to 5.9% of its shares through open market purchases. Shares repurchase plans are usually a sign that the company's board believes its shares are undervalued.
MetLife Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 9th. Stockholders of record on Tuesday, August 5th will be paid a $0.5675 dividend. The ex-dividend date is Tuesday, August 5th. This represents a $2.27 annualized dividend and a dividend yield of 2.90%. MetLife's dividend payout ratio is currently 36.91%.
About MetLife
(
Free Report)
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
See Also

Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.